Can Diclofenac Affect Your Kidneys?

Diclofenac can harm your kidneys, though for most healthy people taking it short-term, the risk is low. The drug works by blocking enzymes that produce prostaglandins, and those same prostaglandins happen to play a protective role in kidney blood flow. When that protection drops, the kidneys become vulnerable, especially if you are dehydrated, elderly, already have kidney problems, or take certain other medications at the same time. The range of kidney effects runs from mild fluid retention all the way to acute kidney failure, so the details matter more than the headline.

How Diclofenac Reaches the Kidneys

Diclofenac belongs to the class of nonsteroidal anti-inflammatory drugs. Like other NSAIDs, it works by blocking two enzymes, COX-1 and COX-2, that your body uses to make prostaglandins. Prostaglandins drive inflammation and pain, so blocking them is what makes the drug useful. But prostaglandins also do housekeeping work throughout the body, and nowhere is that housekeeping more consequential than in the kidneys.

Your kidneys depend on prostaglandins to keep their blood vessels open, particularly the tiny arterioles that feed the filtering units. When the body is under stress from dehydration, blood loss, or low blood pressure, vasoconstrictor signals ramp up and try to squeeze those vessels shut. Prostaglandins push back, keeping enough blood flowing to maintain filtration. Take away the prostaglandins with an NSAID like diclofenac and that counterbalance disappears. Blood flow to the kidneys drops, the filtration rate falls, and the organs start struggling to do their job.¹ This is not a quirk of diclofenac specifically; it is the shared pharmacology of the entire NSAID class. Diclofenac inhibits COX-1 and COX-2 with roughly equal potency, which means it hits both the inflammatory pathway and the kidney-protective pathway at the same time.

In a healthy, well-hydrated person whose kidneys are not under any particular strain, this drop in prostaglandin activity is usually small enough that the body compensates without trouble. A short course of diclofenac at standard doses in young, healthy adults has been shown to produce no significant changes in kidney filtration or blood pressure.² The problems start when something tips the balance: existing kidney disease, volume depletion, old age, or medications that compound the effect.

Acute Kidney Injury

Acute kidney injury, where kidney function drops suddenly over hours to days, is the most dramatic renal risk from diclofenac. It can show up in several forms. The most common is a straightforward drop in blood flow to the kidneys caused by the prostaglandin mechanism described above. Less frequently, diclofenac triggers an immune-mediated reaction in which the kidney tissue itself becomes inflamed, a condition called acute interstitial nephritis. One documented case involved a 73-year-old woman who developed both interstitial nephritis and nephrotic syndrome after six months on diclofenac, requiring a kidney biopsy to confirm what had happened.³

A systematic review and meta-analysis examining individual NSAIDs found that diclofenac users had an elevated risk of acute kidney injury, though the increase did not reach statistical significance when diclofenac was analyzed in isolation from other NSAIDs.⁴ That does not mean the risk is zero; it means that in the pooled data, the confidence interval was too wide to call it definitive. In practice, clinicians treat all NSAIDs, diclofenac included, as carrying meaningful acute kidney risk in vulnerable patients.

Animal research paints a more alarming picture when kidneys already have hidden damage. In rats with subclinical kidney injury that was not yet producing symptoms, a single high oral dose of diclofenac worsened the acute tubular damage within 24 hours and led to scarring and atrophy within two weeks, effectively converting a silent injury into chronic kidney disease.⁵ The lower dose tested in the same study did not produce this effect, suggesting dose matters a great deal. Animal models do not translate directly to humans, but the finding reinforces the clinical concern that people with undiagnosed, early-stage kidney trouble may be particularly vulnerable.

Fluid Retention, Electrolytes, and Blood Pressure

Even when diclofenac does not cause outright kidney failure, it can quietly disrupt the kidneys’ ability to manage salt, water, and electrolytes. Because prostaglandins help regulate sodium excretion and water balance, blocking them often leads to fluid retention, which can show up as swollen ankles or a noticeable jump in blood pressure. These effects are shared across NSAIDs and tend to depend on dose and how long you take the drug.⁶

Beyond simple fluid retention, NSAIDs including diclofenac can push potassium levels up and sodium levels down. High potassium is especially concerning for people on other drugs that also raise potassium, such as ACE inhibitors or potassium-sparing diuretics, because the combined effect can become dangerous for the heart. Low sodium, meanwhile, can produce confusion, nausea, and fatigue.⁷ If you are taking diclofenac after a major surgery, monitoring urine output and blood potassium is a standard precaution for exactly this reason.⁸

Who Is Most at Risk

Your baseline kidney health and hydration status are the biggest predictors of whether diclofenac will cause you trouble. Some groups face disproportionate risk:

• Older adults: Age-related decline in kidney function means there is less reserve to absorb the hit from prostaglandin suppression. In elderly subjects, even a single dose of diclofenac measurably impairs kidney function, and the impairment is more pronounced when they are also taking an ACE inhibitor.⁹
• Anyone who is dehydrated: Volume depletion activates the body’s vasoconstrictor systems, making prostaglandin protection more critical. Acute kidney failure has been reported from a single dose of diclofenac in a dehydrated child.¹⁰
• Children with vomiting or diarrhea: Pediatric cases of acute kidney failure after NSAIDs are increasingly recognized, almost always in the context of dehydration from illness.¹¹
• People with existing kidney disease: If the kidneys are already compromised, even a small drop in prostaglandin-mediated blood flow can push them over the edge.
• Post-surgical patients: Surgery often involves blood loss, fluid shifts, and fasting, all of which reduce kidney perfusion. A case report described acute kidney failure in a decompensated elderly patient following diclofenac use, underscoring the importance of adequate hydration before administering the drug.¹²

The common thread is that diclofenac becomes dangerous when the kidneys are already leaning on prostaglandins to maintain adequate blood flow. In a well-hydrated person with normal kidney function, the body has enough spare capacity to tolerate the prostaglandin dip. Remove that spare capacity and the drug becomes a real threat.

The “Triple Whammy” Drug Combination

One of the most well-documented kidney risks involving diclofenac is not about the drug alone but about what you take alongside it. The so-called triple whammy refers to the combination of an NSAID (like diclofenac), a diuretic (a water pill), and an ACE inhibitor or angiotensin receptor blocker. Each of these drugs affects kidney blood flow through a different mechanism, and together they can overwhelm the kidneys’ ability to compensate.¹³

A large nested case-control study found that people on all three drugs simultaneously had a substantially increased risk of acute kidney injury, and the risk was highest during the first 30 days. In that initial period, the risk of acute kidney injury was about 82% higher compared to periods without the triple combination. After 90 days of continuous use, the elevated risk essentially disappeared, suggesting that either the most vulnerable patients had already been identified or the kidneys adapted.¹⁴ The same study noted that NSAIDs with longer half-lives tended to carry a higher risk in these combinations; diclofenac’s relatively short half-life of about two hours may offer a modest safety margin compared to longer-acting alternatives, though it is not a guarantee.

If you take blood pressure medication, especially a combination of a diuretic and an ACE inhibitor or ARB, this is the scenario you should know about. Adding diclofenac, even over the counter, without consulting your doctor can tip your kidneys into real trouble, particularly during the first month.

Long-Term Use and Chronic Kidney Disease

Occasional use of diclofenac for a headache or a sprained ankle is a fundamentally different exposure than taking it every day for months. One case report documented a patient who took diclofenac in combination with acetaminophen for roughly a year and was eventually diagnosed with drug-induced chronic kidney disease, along with hypertension and anemia.¹⁵ That is an extreme example, and single case reports cannot tell us how common an outcome is, but it illustrates the trajectory that chronic NSAID exposure can follow.

A broader review of the literature that examined hundreds of studies concluded that NSAIDs at regular doses are generally well-tolerated but that high-dose, long-term use may contribute to chronic kidney disease progression. The same review noted that for drugs like diclofenac, whose short half-life means it clears the body relatively quickly, regular doses need not be strictly avoided even in people with moderate to severe chronic kidney disease, provided the drug is not otherwise contraindicated.¹⁶ That is a more nuanced position than “never use NSAIDs if your kidneys are weak,” and it reflects the reality that pain management sometimes requires trade-offs. But the general direction is clear: the longer and more heavily you rely on diclofenac, the more kidney monitoring you need.

How Diclofenac Compares to Other NSAIDs

A reasonable question is whether diclofenac is better or worse for the kidneys than ibuprofen, naproxen, or celecoxib. The evidence does not paint any NSAID as entirely kidney-safe, but there are some differences worth knowing. A large trial comparing celecoxib, diclofenac, and ibuprofen found that among patients who already had mild prerenal azotemia (slightly impaired kidney blood flow), about 7.3% of diclofenac users experienced a clinically important reduction in kidney function, compared to 3.7% of celecoxib users. Ibuprofen matched diclofenac at 7.3%.¹⁷ Celecoxib’s somewhat better renal profile in that trial may relate to its greater COX-2 selectivity, though the differences are modest and do not mean celecoxib is harmless to kidneys.

One area where diclofenac may have a safety advantage is in topical form. Gels and patches deliver the drug locally, with far less reaching the bloodstream. A study specifically examining long-term use of topical diclofenac gel in seniors and patients with cardiovascular disease, diabetes, or hypertension found no notable increase in adverse events, suggesting that topical delivery largely sidesteps the systemic kidney risk.¹⁸ If your pain is in a joint or muscle that a gel can reach, the topical route is worth discussing with your doctor as a way to get relief while keeping your kidneys out of the line of fire.

Diclofenac During Pregnancy

The kidney risk extends to developing fetuses. In the third trimester of pregnancy, diclofenac can interfere with fetal kidney function, reducing the amniotic fluid that surrounds and protects the baby. This condition, called oligohydramnios, can be severe. Even in the second trimester, prolonged diclofenac exposure has been linked to reversible drops in amniotic fluid.¹⁹

The mechanism is the same as in adults: prostaglandin suppression reduces blood flow to the fetal kidneys, which in turn reduces the urine output that makes up most of the amniotic fluid in later pregnancy. Case reports describe newborns who developed kidney failure after their mothers took diclofenac during pregnancy, with outcomes ranging from transient impairment that resolved to irreversible damage.²⁰ The authors of that report recommended avoiding diclofenac entirely during pregnancy. Current guidance from regulatory agencies broadly aligns with that advice, particularly for the third trimester.

What Happens to Kidney Cells

Beyond the hemodynamic squeeze on blood flow, there is evidence that diclofenac can directly damage kidney cells. Laboratory research found that diclofenac triggers oxidative stress within kidney tissue, producing reactive oxygen species that fragment DNA in tubular cells. The end result is widespread programmed cell death, or apoptosis, visible on microscopy as damaged nuclei lining the kidney tubules.²¹ This adds a layer of direct toxicity on top of the blood-flow problem, and it may help explain why some patients develop kidney damage that does not fully reverse once the drug is stopped.

The Vulture Catastrophe

Perhaps the most dramatic illustration of diclofenac’s kidney toxicity comes not from human medicine but from wildlife. Across South Asia, three species of Gyps vultures suffered population crashes of more than 95% starting in the 1990s, pushing them to critically endangered status. The cause was traced to diclofenac residues in the livestock carcasses the birds scavenged.²² Diclofenac killed millions of vultures through a combination of reduced kidney filtration and direct damage to kidney tubules, the same two-hit mechanism that threatens human kidneys, except that vultures are orders of magnitude more sensitive to it.²³

India banned veterinary diclofenac in 2006 and promoted meloxicam as a safer alternative for livestock. Several other South Asian countries followed. The vulture story is a stark reminder that diclofenac’s kidney effects are not subtle pharmacological curiosities; they are powerful enough to reshape ecosystems. It also highlights how species-specific drug metabolism can turn a manageable risk in one organism into a lethal one in another.